Suppr超能文献

载脂蛋白 C-III 抑制剂 alirocumab 治疗家族性乳糜微粒血症综合征伴早发性 ASCVD:一个病例报告

Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report.

机构信息

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

出版信息

BMC Pregnancy Childbirth. 2020 May 6;20(1):272. doi: 10.1186/s12884-020-02965-1.

Abstract

BACKGROUND

Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive lipid disorder often associated with recurrent episodes of pancreatitis. It is documented in most cases with FCS due to the mutations of key proteins in lipolysis, including LPL, APOC2, APOA5, LMF1 and GPIHBP1.

CASE PRESENTATION

We report the successful management of a 35-year-old pregnant woman carrying a novel homozygous frameshift mutation c.48_49insGCGG (p.P17A fs*22) in the GPIHBP1 gene with previous severe episodes of acute pancreatitis triggered by pregnancy, resulting in adverse obstetrical outcomes. With careful monitoring, the patient underwent an uneventful pregnancy and delivered a baby with no anomalies.

CONCLUSIONS

The case report contributes to the understanding of GPIHBP1-deficient familial chylomicronemia syndrome (FCS) and highlights gestational management of FCS patient.

摘要

背景

家族性乳糜微粒血症综合征(FCS)是一种罕见的常染色体隐性脂质代谢紊乱疾病,常伴有反复发作的胰腺炎。大多数 FCS 病例是由于脂肪分解关键蛋白(包括 LPL、APOC2、APOA5、LMF1 和 GPIHBP1)的突变引起的。

病例介绍

我们报告了一例成功管理的 35 岁孕妇,她携带 GPIHBP1 基因中的新型纯合移码突变 c.48_49insGCGG(p.P17A fs*22),此前曾因妊娠引发严重急性胰腺炎,导致不良产科结局。经过仔细监测,患者顺利妊娠并分娩出无异常的婴儿。

结论

该病例报告有助于了解 GPIHBP1 缺陷型家族性乳糜微粒血症综合征(FCS),并强调了 FCS 患者的妊娠期管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2862/7201967/4c7e7ae5972a/12884_2020_2965_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验